🇺🇸 FDA

Company profile · Sponsor

SINOVAC

SINOVAC BIOTECH LTD

SVA · NYSE biotech BEIJING, USA
Pipeline
24
Drugs
0
Patents
0

Quick answer

SINOVAC (SVA) is a biotech company. headquartered in BEIJING, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker SVA
Exchange NYSE
Company type biotech
Headquarters BEIJING, USA
SEC CIK 0001084201

Pipeline (24)

Search pipeline →

  1. 36-71 months old children-experimental EV71 vaccine.

    SINOVAC

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  2. 400U /0.5ml EV71 vaccine

    SINOVAC

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  3. Adsorbed COVID-19 (inactivated) Vaccine

    SINOVAC

    COVID-19

    phase 3 mab completed

    1 trial

  4. COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

    SINOVAC

    COVID-19

    phase 3 mab completed

    1 trial

  5. COVID-19 Vaccine,Inactivated

    SINOVAC

    COVID-19

    phase 3 mab completed

    1 trial

  6. Experimental vaccine

    SINOVAC

    Poliomyelitis

    phase 3 mab completed

    1 trial

  7. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

    SINOVAC

    Seasonal Influenza

    phase 3 mab completed

    1 trial

  8. Investigational live attenuated mumps vaccine

    SINOVAC

    Mumps

    phase 3 mab completed

    2 trials

  9. Investigational sIPV

    SINOVAC

    Poliomyelitis

    phase 3 mab completed

    1 trial

  10. Investigational tetanus vaccine, adsorbed

    SINOVAC

    Tetanus

    phase 3 mab completed

    1 trial

  11. Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

    SINOVAC

    Varicella

    phase 3 mab active

    1 trial

  12. Medium-dosage COVID-19 Vaccine,Inactivated

    SINOVAC

    COVID-19

    phase 3 mab terminated

    1 trial

  13. PROVARIX

    SINOVAC

    Varicella (Chickenpox)

    phase 3 mab active

    1 trial

  14. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    SINOVAC

    Influenza

    phase 3 mab active

    1 trial

  15. Quadrivalent influenza vaccine

    SINOVAC

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  16. Quadrivalent influenza vaccine(0.25ml)

    SINOVAC

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  17. Rabies Vaccine (Serum-free Vero Cell), Freeze-dried

    SINOVAC

    Rabies

    phase 3 mab active

    2 trials

  18. Rabies vaccine

    SINOVAC

    Rabies (Healthy Volunteers)

    phase 3 mab active

    1 trial

  19. SARS-CoV-2 inactivated vaccine

    SINOVAC

    Covid19

    phase 3 mab completed

    1 trial

  20. SARS-CoV-2 vaccine (inactivated)

    SINOVAC

    SARS-CoV2 Infection

    phase 3 mab completed

    1 trial

  21. Sabin Strain Inactivated Poliovirus Vaccine

    SINOVAC

    Poliomyelitis

    phase 3 mab completed

    1 trial

  22. Sinovac PCV13

    SINOVAC

    Pneumococcal Infectious Disease

    phase 3 mab active

    2 trials

  23. Sinovac PCV13

    SINOVAC

    Pneumococcal Infectious Diseases

    phase 3 mab active

    1 trial

  24. Sinovac rabies vaccine

    SINOVAC

    Rabies (Healthy Volunteers)

    phase 3 mab active

    2 trials

Frequently asked questions

What is SINOVAC?

SINOVAC (SVA) is a biotech company. headquartered in BEIJING, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does SINOVAC sponsor?

We track 24 ClinicalTrials.gov-linked programs for SINOVAC, including 36-71 months old children-experimental EV71 vaccine. and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does SINOVAC company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.